Source: International Congress 2015 – IIPs: orphan
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mitsuko Kondo (Tokyo, Japan), Mitsuko Kondo, Ken Arimura, Kiyoshi Takeyama, Etsuko Tagaya, Jun Tamaoki. The clinical significance of 24hr continuous monitoring of SpO2 during daily life in the patients with interstitial pneumonia. Eur Respir J 2015; 46: Suppl. 59, 3825

Member's Comments

No comment yet.

Related content which might interest you: Baseline characteristics and survival of patients with pulmonary hypertension in interstitial lung disease in the “HYPID” study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013 PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Clinical experience with nintedanib for the treatment of IPF in 80 cases Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Source: International Congress 2015 – Treatment of IPF Year: 2015 Longitudinal change in non-invasive markers in interstitial lung disease associated pulmonary hypertension and correlation with invasive pulmonary haemodynamics Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Treatment of severe pulmonary hypertension in patients with interstitial lung disease: Results in 72 patients from the “HYPID” prospective study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 Pulmonary hypertension in interstitial lung disease: Non-invasive assessment for detection and prognosis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Pulmonary hypertension in patients with interstitial lung disease Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Noninvasive positive pressure ventilation in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches Year: 2006 Effect of baseline corticosteroid medication on reduction in FVC decline with nintedanib Source: International Congress 2015 – Treatment of IPF Year: 2015 Effect of baseline composite physiologic index on benefit of nintedanib in IPF Source: International Congress 2016 – IPF treatment I Year: 2016 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Scoring system predicting for elevation of MPAP in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Patterns of cardiopulmonary response to exercise in lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69 Year: 2007 Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary vascular response patterns during exercise in interstitial lung disease (ILD) Source: International Congress 2014 – Mechanisms of exercise limitation in disease Year: 2014 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Non-invasive ventilation in the management of acute respiratory failure in patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – Expanding the use of noninvasive ventilation in acute respiratory failure Year: 2014